PHOENIX, Nov. 7, 2016 /PRNewswire/ -- (OTC-PINK: LBTD) Lotus Biotechnology Development, Inc. is pleased to announce
"The next couple months are expected to be very exciting, as we begin the roll out of new products to market. We plan to be updating investors every step of the way, as our new product line is incrementally unveiled," stated: Michael Palethorpe, Chief Executive Officer and President, Lotus Biotechnologies.
The Company has invested great effort in the intricate formulation of top quality organics over the past several years. Aggressively driving the Company's brand to the top of the marketplace has been among management's main corporate objectives. With these factors to build upon, the Company has mobilized to carefully incorporate CBD into its products, thereby capitalizing on the Company's brand recognition to drive a successful launch into the CBD market.
Lotus Biotechnologies has formed a strong team to produce and process the Company's Organic materials in new strands of CBD that are slated for sales in 4 states with licensing in place. With the Company's newly formed group and processing plant, Lotus Biotechnologies has launched its first subsidiary. Details can be found at http://lotusmedicalcbd.com/#products.
Mr Palethorpe continued: "We have been silently laboring for several years to be able to lay claim on being a producer of one of the finest quality lines in the industry. With great anticipation of whats ahead, we are very pleased with the result of having created such a highly desirable product line."
The terms of the agreement include the purchase of assets from CBD SOCO. Lotus Bio-Technologies has strategized to facilitate a new processing center in Eastern KY to produce and manufacture all CBD Oils. Due to the Company's rising success in the production of specialty organic mechandise, Lotus Bio-Technologies has determined that the timing on this acquisition has the potential to fuel exponential growth for the Company.
The size of the market for legal marijuana in the United States is projected to grow to $7.1 billion in 2016, according to a report by New Frontier and ArcView Market Research. That represents 26% growth over the previous year, driven largely by adult recreational sales of marijuana, according to research cited on Forbes.com website.
Safe Harbor Statement:
This press release may contain certain forward-looking statements. These statements are any statements that are not of historical fact and may be deemed to be forward-looking statements made by management that express their belief at the time they are made regarding the Company's results of operations, possible profits, financial developments business activities, and potential for success in various aspects of our operations. You can identify forward-looking statements as those that are not historical in nature, particularly those that use terminology such as "may", "will", "should", "expects", "anticipates", "contemplates", "estimates", "believes", "plans", "projects", "predicts", "potential" or "continue" or the negative of these similar terms. In evaluating these forward-looking statements, you should consider various factors, including the following: (a) those risks and uncertainties related to general economic conditions, (b) whether we are able to manage our planned growth efficiently and operate profitably, (c) whether we are able to generate sufficient revenues or obtain financing to sustain and grow our operations, and (d) whether we are able to successfully fulfill our primary requirements for cash. The Company's actual results may differ significantly from the results projected in the forward-looking statements. The Company assumes no obligation to update forward-looking statements.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lotus-bio-technology-development-corporation-signs-definitive-agreement-with-cbd-soco-and-launches-production-on-exclusive-organic-cbd-merchandise-300358311.html
SOURCE Lotus Biotechnology Development, Corp.
Subscribe to our Free Newsletters!